Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures
NCT00275925 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2007-11-30
Summary
This study is aimed to evaluate the efficacy, safety and tolerability of oxcarbazepine monotherapy in adults with partial seizures.
Conditions
- Epilepsy, Partial Seizures
Interventions
- DRUG
-
Oxcarbazepine
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-12-31
- Completion
- 2007-03-31
Countries
- Russia
Study Locations
More Related Trials
-
Pediatric Epilepsy Study
NCT00050934 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures
NCT00975715 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures
NCT00772603 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Pharmacokinetics (PK) and Safety of IV Carbamazepine Relative to Oral Carbamazepine in Adults With Epilepsy
NCT01079351 ·Status: COMPLETED ·Phase: PHASE1
-
Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients
NCT00918047 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
NCT01128959 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures
NCT01167335 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine
NCT00900237 ·Status: COMPLETED ·Phase: PHASE1
-
Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy
NCT00280059 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
NCT00866775 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
NCT00150293 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144
NCT07198035 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures
NCT01162460 ·Status: COMPLETED ·Phase: PHASE3
-
Study of VX-765 in Subjects With Treatment-resistant Partial Epilepsy
NCT01048255 ·Status: COMPLETED ·Phase: PHASE2
-
GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
NCT00567424 ·Status: WITHDRAWN ·Phase: PHASE2
-
To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
NCT00141245 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy
NCT02495844 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy
NCT00908349 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Study of the Safety of OXC XR as in Pediatric Epilepsy Subjects
NCT00918424 ·Status: APPROVED_FOR_MARKETING
-
A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.
NCT00740623 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures
NCT00437281 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery
NCT00887861 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients
NCT01422720 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies
NCT03650452 ·Status: COMPLETED ·Phase: PHASE2
-
A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093
NCT02171195 ·Status: COMPLETED ·Phase: PHASE1